There is a shortage of a key chemotherapy medication
and that's affecting how cancer patients are being treated.
93% of cancer centers surveyed by the National Comprehensive
Cancer Network are reporting a shortage of carboplatin.
70% of these centers say they don't have enough of a drug called CYS plant. Now,
combination these two medications are used to cure numerous types of cancer.
The network's chief executive Officer is
calling the situation just unacceptable.
Now, in a statement, he says, quote,
we are hearing from oncologists and pharmacists across the country who have to
scramble to find appropriate alternatives for treating
their patients with cancer right now.
Now there is an overall shortage of medications in the US. But officials say
cancer treatments in particular
have been among some of the hardest hit.